{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:56:27Z","timestamp":1771458987539,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s43032-024-01540-9","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T17:01:29Z","timestamp":1712854889000},"page":"2371-2378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The sFLT-1\/PlGF Ratio for the Prediction of Preeclampsia-Related Adverse Fetal and Maternal Outcomes in Women with Preexisting Diabetes"],"prefix":"10.1007","volume":"31","author":[{"given":"Anais","family":"Provendier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Migliorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lola","family":"Loussert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice Guyard","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Vayssiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safouane M.","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Hanaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninon","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-4351","authenticated-orcid":false,"given":"Paul","family":"Guerby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"issue":"5","key":"1540_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","volume":"15","author":"EA Phipps","year":"2019","unstructured":"Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):275\u201389.","journal-title":"Nat Rev Nephrol Mai"},{"issue":"1","key":"1540_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and Management recommendations for International Practice. Hypertens. 2018;72(1):24\u201343.","journal-title":"Hypertens Juill"},{"issue":"6","key":"1540_CR3","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","volume":"135","author":"Gestational Hypertension and Preeclampsia","year":"2020","unstructured":"Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237\u201360.","journal-title":"Obstet Gynecol juin"},{"issue":"1","key":"1540_CR4","first-page":"62","volume":"9","author":"BM Sibai","year":"2000","unstructured":"Sibai BM. Risk factors, pregnancy complications, and prevention of hypertensive disorders in women with pregravid diabetes mellitus. J Matern Fetal Med. 2000;9(1):62\u20135.","journal-title":"J Matern Fetal Med f\u00e9vr"},{"issue":"2","key":"1540_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0002-9378(90)91184-E","volume":"163","author":"PR Garner","year":"1990","unstructured":"Garner PR, D\u2019Alton ME, Dudley DK, Huard P, Hardie M. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol. 1990;163(2):505\u20138.","journal-title":"Am J Obstet Gynecol ao\u00fbt"},{"issue":"1","key":"1540_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2337\/dc09-1219","volume":"33","author":"DM Jensen","year":"2010","unstructured":"Jensen DM, Damm P, Ovesen P, Molsted-Pedersen L, Beck-Nielsen H, Westergaard JG, et al. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care. 2010;33(1):90\u20134.","journal-title":"Diabetes Care 1 janv"},{"key":"1540_CR7","doi-asserted-by":"crossref","unstructured":"Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER. Pregnancy outcome in type 1 Diabetic Women with microalbuminuria. Diabetes Care. 2001;1(10):1739\u201344.","DOI":"10.2337\/diacare.24.10.1739"},{"issue":"2","key":"1540_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0002-9378(00)70225-0","volume":"182","author":"BM Sibai","year":"2000","unstructured":"Sibai BM, Caritis S, Hauth J, Lindheimer M, VanDorsten JP, MacPherson C, et al. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. Am J Obstet Gynecol. 2000;182(2):364\u20139.","journal-title":"Am J Obstet Gynecol f\u00e9vr"},{"issue":"5","key":"1540_CR9","first-page":"802","volume":"82","author":"CA Combs","year":"1993","unstructured":"Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol. 1993;82(5):802\u20137.","journal-title":"Obstet Gynecol Nov"},{"issue":"4","key":"1540_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/ceo.12760","volume":"44","author":"JL Morrison","year":"2016","unstructured":"Morrison JL, Hodgson LA, Lim LL, Al-Qureshi S. Diabetic retinopathy in pregnancy: a review. Clin Exp Ophthalmol. 2016;44(4):321\u201334.","journal-title":"Clin Exp Ophthalmol Mai"},{"issue":"6","key":"1540_CR11","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1046\/j.1464-5491.2002.00729.x","volume":"19","author":"T Cundy","year":"2002","unstructured":"Cundy T, Slee F, Gamble G, Neale L. Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes: original article. Diabet Med. 2002;19(6):482\u20139.","journal-title":"Diabet Med juin"},{"key":"1540_CR12","doi-asserted-by":"publisher","first-page":"101126","DOI":"10.1016\/j.redox.2019.101126","volume":"22","author":"P Guerby","year":"2019","unstructured":"Guerby P, Swiader A, Aug\u00e9 N, Parant O, Vayssi\u00e8re C, Uchida K, et al. High glutathionylation of placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 2019;22:101126.","journal-title":"Redox Biol avr"},{"key":"1540_CR13","doi-asserted-by":"publisher","first-page":"101861","DOI":"10.1016\/j.redox.2021.101861","volume":"40","author":"P Guerby","year":"2021","unstructured":"Guerby P, Tasta O, Swiader A, Pont F, Bujold E, Parant O, et al. Role of oxidative stress in the dysfunction of the placental endothelial nitric oxide synthase in preeclampsia. Redox Biol. 2021;40:101861.","journal-title":"Redox Biol avr"},{"key":"1540_CR14","doi-asserted-by":"crossref","unstructured":"Levine RJ, Lim KH, Schisterman EF, Sachs BP, Sibai BM, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;12.","DOI":"10.1056\/NEJMoa031884"},{"key":"1540_CR15","doi-asserted-by":"crossref","unstructured":"Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA. 1993;90(22):10705\u20139.","DOI":"10.1073\/pnas.90.22.10705"},{"issue":"5","key":"1540_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649\u201358.","journal-title":"J Clin Invest 1 mars"},{"issue":"S 01","key":"1540_CR17","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1055\/s-0040-1709696","volume":"38","author":"O Tasta","year":"2021","unstructured":"Tasta O, Parant O, Hamdi SM, Allouche M, Vayssiere C, Guerby P. Evaluation of the prognostic value of the sFlt-1\/PlGF ratio in early-onset preeclampsia. Am J Perinatol. 2021;38\u00a0\u00a0(S 01):e292\u20138.","journal-title":"Am J Perinatol ao\u00fbt"},{"issue":"1","key":"1540_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/10641955.2013.837175","volume":"33","author":"AL Cohen","year":"2014","unstructured":"Cohen AL, Wenger JB, James-Todd T, Lamparello BM, Halprin E, Serdy S, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014;33(1):81\u201392.","journal-title":"Hypertens Pregnancy f\u00e9vr"},{"key":"1540_CR19","doi-asserted-by":"crossref","unstructured":"Bonnet MP, Garnier M, Keita H, Comp\u00e8re V, Arthuis C, Raia-Barjat T, et al. Guidelines for the management of women with severe pre-eclampsia. Anaesth Crit Care Pain Med. 2021;40(5):100901.","DOI":"10.1016\/j.accpm.2021.100901"},{"key":"1540_CR20","unstructured":"AUDIPOG (n.d.) Courbes morphom\u00e9triques n\u00e9onatales. Available from https:\/\/www.audipog.net\/Courbes-morpho."},{"key":"1540_CR21","doi-asserted-by":"crossref","unstructured":"L\u00e9vy P, Hamdi S, Guiboudenche J, Haguet MC, Bailleul S, Lef\u00e8vre G. Applying the concept of uncertainty to the sFlt-1\/PlGF cut-offs for diagnosis and prognosis of preeclampsia. Clin Chem Lab Med. 2021;59(4):681\u20136.","DOI":"10.1515\/cclm-2020-0477"},{"issue":"1","key":"1540_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/1471-2393-14-324","volume":"14","author":"M Hund","year":"2014","unstructured":"Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth. 2014;14(1):324.","journal-title":"BMC Pregnancy Childbirth d\u00e9c"},{"key":"1540_CR23","doi-asserted-by":"crossref","unstructured":"Hanson E, Rull K, Ratnik K, Vaas P, Teesalu P, Laan M. Value of soluble fms-like tyrosine kinase-1\/placental growth factor test in third trimester of pregnancy for predicting preeclampsia in asymptomatic women. J Perinat Med. 2022;27(7):939\u201346.","DOI":"10.1515\/jpm-2022-0127"},{"issue":"1","key":"1540_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00125-008-1182-x","volume":"52","author":"Y Yu","year":"2009","unstructured":"Yu Y, Jenkins AJ, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, et al. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women. Diabetologia. 2009;52(1):160\u20138.","journal-title":"Diabetologia janv"},{"issue":"3","key":"1540_CR25","first-page":"244","volume":"197","author":"TA Moore Simas","year":"2007","unstructured":"Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol. 2007;197(3):244. e1-244.e8.","journal-title":"Am J Obstet Gynecol sept"},{"key":"1540_CR26","doi-asserted-by":"crossref","unstructured":"Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in Preeclampsia. N Engl J Med. 2006;7(10):992\u20131005.","DOI":"10.1056\/NEJMoa055352"},{"key":"1540_CR27","doi-asserted-by":"crossref","unstructured":"Bednarek-J\u0119drzejek M, Kwiatkowski S, Ksel-Hryci\u00f3w J, Tousty P, Nurek K, Kwiatkowska E, et al. The sFlt-1\/PlGF ratio values within the <\u200938, 38\u201385 and >\u200985 brackets as compared to perinatal outcomes. J Perinat Med. 2019;25(7):732\u201340.","DOI":"10.1515\/jpm-2019-0019"},{"key":"1540_CR28","doi-asserted-by":"crossref","unstructured":"Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr\u00f6m M et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13\u201322.","DOI":"10.1056\/NEJMoa1414838"},{"issue":"12","key":"1540_CR29","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.2337\/diacare.27.12.2819","volume":"27","author":"DM Jensen","year":"2004","unstructured":"Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27(12):2819\u201323.","journal-title":"Diabetes Care d\u00e9c"},{"issue":"11","key":"1540_CR30","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.2337\/dc09-0656","volume":"32","author":"M Persson","year":"2009","unstructured":"Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care. 2009;32(11):2005\u20139.","journal-title":"Diabetes Care Nov"},{"issue":"9\u201310","key":"1540_CR31","first-page":"397","volume":"57","author":"KM Knight","year":"2012","unstructured":"Knight KM, Thornburg LL, Pressman EK. Pregnancy outcomes in type 2 diabetic patients as compared with type 1 diabetic patients and nondiabetic controls. J Reprod Med. 2012;57(9\u201310):397\u2013404.","journal-title":"J Reprod Med oct"},{"issue":"14","key":"1540_CR32","first-page":"1933","volume":"31","author":"M Vestgaard","year":"2018","unstructured":"Vestgaard M, Sommer MC, Ringholm L, Damm P, Mathiesen ER. Prediction of preeclampsia in type 1 diabetes in early pregnancy by clinical predictors: a systematic review. J Matern Fetal Neonatal Med. 2018;31(14):1933\u20139.","journal-title":"J Matern-Fetal Neonatal Med off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet Juill"},{"issue":"3","key":"1540_CR33","first-page":"75","volume":"201","author":"W Schr\u00f6der","year":"1997","unstructured":"Schr\u00f6der W, Heyl W. [Diabetic nephropathy and pregnancy]. Z Geburtshilfe Neonatol. 1997;201(3):75\u201381.","journal-title":"Z Geburtshilfe Neonatol juin"},{"issue":"12","key":"1540_CR34","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1007\/s001250051565","volume":"43","author":"V Hiilesmaa","year":"2000","unstructured":"Hiilesmaa V, Suhonen L, Teramo K. Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia. 2000;43(12):1534\u20139.","journal-title":"Diabetologia d\u00e9c"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01540-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-024-01540-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01540-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T10:06:02Z","timestamp":1722333962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-024-01540-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1007\/s43032-024-01540-9","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}